Why Mid-Sized Enterprises Are Struggling With AI Integration and How IT Leaders Can Fix the Architecture Gap in 2026 
New Survey Highlights Gap Between Perceived AI Readiness And Tested Disaster Recovery Capability 
Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation Yield10 Bioscience to Present at the Benzinga Biotech Small Cap Conference on March 25, 2021
WOBURN, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference
CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology…
ORYZON to Participate in Upcoming Virtual International Conferences in March and April
BIO-Europe Spring 2021 Kempen Life Sciences Conference 4th SACHS Annual Neuroscience Innovation Forum 2021 MADRID,…
Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
Company to host an investor conference call and webcast at 4:30pm ET on that day…
APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
Cary, NC, March 18, 2021 (GLOBE NEWSWIRE) — APIE Therapeutics, a preclinical biopharma company pioneering…
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world…
Alimera Sciences to Participate in Benzinga Biotech Small Cap Conference
ATLANTA, March 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical…
Foghorn Therapeutics Provides Corporate Update
– FHD-286 Phase 1 data anticipated as early as year-end 2021 – FHD-609 IND submission…
Celularity Announces Fast Track Designation by the FDA for its Natural Killer Cell Therapy CYNK-001 in the Treatment of Recurrent Glioblastoma Multiforme
FLORHAM PARK, N.J., March 18, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (“Celularity”), a clinical-stage biotechnology…
Neoleukin Therapeutics to Host 2020 Financial Results Conference Call and Webcast on March 25, 2021
SEATTLE, March 18, 2021 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
Pyxis expands developmental capabilities with license to two ADC programs and ADC technology platform toolkit…
Talis Appoints Jeryl Hilleman to Board of Directors
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Entera Bio Ltd Announces Operating and Financial Results for the Fourth Quarter and Year Ended December 31, 2020
‒ Achieved Primary Endpoint in EB613 Phase 2 Clinical Trial ‒‒ Final Data, Including Bone…
ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
Conference Call Scheduled for March 25, 2021 at 4:30 p.m. ET RAMSEY, N.J. and BOCA…
Avadel Pharmaceuticals to Participate in a Fireside Chat at Stifel’s Third Annual CNS Day on March 31st
DUBLIN, Ireland, March 18, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
Generation Bio Reports Fourth Quarter and Full Year 2020 Financial Results
$262.3 million cash balance at the end of 2020 bolstered by additional net proceeds of…
Acepodia to Present at the 6th Annual Innate Killer Summit
SAN MATEO, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Acepodia, a biotechnology company developing next…
Ocugen Provides Business Update and Full Year 2020 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy…
ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent Director
SINGAPORE, March 18, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to…
Plus Therapeutics to Participate in Upcoming Virtual Conferences
AUSTIN, Texas, March 18, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…